{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T09:00:58Z","timestamp":1772355658586,"version":"3.50.1"},"reference-count":70,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["PROMETEOII\/2015\/021"],"award-info":[{"award-number":["PROMETEOII\/2015\/021"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/01770"],"award-info":[{"award-number":["PI16\/01770"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Fundaci\u00f3n para el Fomento de la Investigaci\u00f3n Sanitaria y Biom\u00e9dica de la Comunitat Valenciana","doi-asserted-by":"publisher","award":["UGP-14- 184"],"award-info":[{"award-number":["UGP-14- 184"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2020,1,7]]},"abstract":"<jats:sec><jats:title>Aims:<\/jats:title><jats:p>Oxidative stress is increased during the acute phases of bipolar disorder (BD). Our aim here was to analyze oxidative stress biomarkers in patients with BD during euthymia and their siblings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method:<\/jats:title><jats:p>A cross-sectional study was performed in euthymic patients with BD-I (n=48), unaffected siblings (n=23) and genetically unrelated healthy controls (n=21). Protein carbonyl content (PCC), total antioxidant capacity (TRAP), lipid peroxidation (TBARS) and uric acid were measured as biomarkers of oxidative stress in blood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>The antioxidant capacity (TRAP) was lower (p&lt;0.001) in patients with BD compared to their siblings and controls, whereas no differences were observed in PCC, TBARS or uric acid. In patients, the concentrations of TRAP and TBARS were positively associated with the dose of valproic acid (p&lt;0.05 and p&lt;0.001, respectively). The concentrations of these biomarkers were not significantly associated with any of socio-demographic and clinical variables.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>A selective reduction in antioxidant capacity is present in BD during euthymia state, whereas other markers of oxidative stress are unaltered during euthymia. Siblings did not show any alterations in oxidative stress biomarkers. Oxidative stress might represent a state-dependent marker in BD. The association between treatment with valproic acid and oxidative stress markers in euthymia deserves further studies.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1871530319666190307165355","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T11:33:12Z","timestamp":1552044792000},"page":"77-86","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Peripheral Oxidative Stress Markers in Patients with Bipolar Disorder during Euthymia and in Siblings"],"prefix":"10.2174","volume":"20","author":[{"given":"Amparo","family":"Tatay-Manteiga","sequence":"first","affiliation":[{"name":"Service of Psychiatry, University General Hospital, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicent","family":"Balanz\u00e1-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Teaching Unit of Psychiatry and Psychological Medicine, Department of Medicine, University of Valencia, CIBERSAM, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovana","family":"Bristot","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Psiquiatria Molecular, Centro de Pesquisa Experimental, Hospital de Cl\u00ednicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Tabar\u00e9s-Seisdedos","sequence":"additional","affiliation":[{"name":"Teaching Unit of Psychiatry and Psychological Medicine, Department of Medicine, University of Valencia, CIBERSAM, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavio","family":"Kapczinski","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, McMaster University, Hamilton, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Cauli","sequence":"additional","affiliation":[{"name":"Department of Nursing, University of Valencia, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/da.20521","volume":"26","author":"Soreca I.","year":"2009","unstructured":"Soreca I.; Frank E.; Kupfer D.J.; The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis? Depress Anxiety 2009,26(1),73-82","journal-title":"Depress Anxiety"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.eurpsy.2011.11.007","volume":"28","author":"Vieta E.","year":"2013","unstructured":"Vieta E.; Popovic D.; Rosa A.R.; Sol\u00e9 B.; Grande I.; Frey B.N.; Martinez-Aran A.; Sanchez-Moreno J.; Balanz\u00e1-Mart\u00ednez V.; Tabar\u00e9s-Seisdedos R.; Kapczinski F.; The clinical implications of cognitive impairment and allostatic load in bipolar disorder. Eur Psychiatry 2013,28(1),21-29","journal-title":"Eur Psychiatry"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1176\/ajp.149.8.999","volume":"149","author":"Post R.M.","year":"1992","unstructured":"Post R.M.; Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992,149(8),999-1010","journal-title":"Am J Psychiatry"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.neubiorev.2007.04.003","volume":"31","author":"Post R.M.","year":"2007","unstructured":"Post R.M.; Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neurosci Biobehav Rev 2007,31(6),858-873","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neubiorev.2007.10.005","volume":"32","author":"Kapczinski F.","year":"2008","unstructured":"Kapczinski F.; Vieta E.; Andreazza A.C.; Frey B.N.; Gomes F.A.; Tramontina J.; Kauer-Sant\u2019anna M.; Grassi-Oliveira R.; Post R.M.; Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev 2008,32(4),675-692","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0018-506X(02)00024-7","volume":"43","author":"McEwen B.S.","year":"2003","unstructured":"McEwen B.S.; Wingfield J.C.; The concept of allostasis in biology and biomedicine. Horm Behav 2003,43(1),2-15","journal-title":"Horm Behav"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jad.2007.03.007","volume":"100","author":"Berk M.","year":"2007","unstructured":"Berk M.; Hallam K.T.; McGorry P.D.; The potential utility of a staging model as a course specifier: a bipolar disorder perspective. J Affect Disord 2007,100(1-3),279-281","journal-title":"J Affect Disord"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","volume":"35","author":"Berk M.","year":"2011","unstructured":"Berk M.; Kapczinski F.; Andreazza A.C.; Dean O.M.; Giorlando F.; Maes M.; Y\u00fccel M.; Gama C.S.; Dodd S.; Dean B.; Magalh\u00e3es P.V.; Amminger P.; McGorry P.; Malhi G.S.; Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2011,35(3),804-817","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/sj.npp.1301575","volume":"33","author":"Schloesser R.J.","year":"2008","unstructured":"Schloesser R.J.; Huang J.; Klein P.S.; Manji H.K.; Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 2008,33(1),110-133","journal-title":"Neuropsychopharmacology"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2011.12.049","volume":"141","author":"Leboyer M.","year":"2012","unstructured":"Leboyer M.; Soreca I.; Scott J.; Frye M.; Henry C.; Tamouza R.; Kupfer D.J.; Can bipolar disorder be viewed as a multi-system inflammatory disease? J Affect Disord 2012,141(1),1-10","journal-title":"J Affect Disord"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.rbp.2012.09.001","volume":"35","author":"Gama C.S.","year":"2013","unstructured":"Gama C.S.; Kunz M.; Magalh\u00e3es P.V.; Kapczinski F.; Staging and neuroprogression in bipolar disorder: a systematic review of the literature. Br J Psychiatry 2013,35(1),70-74","journal-title":"Br J Psychiatry"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11920-013-0425-9","volume":"15","author":"Goldstein B.I.","year":"2013","unstructured":"Goldstein B.I.; Young L.T.; Toward clinically applicable biomarkers in bipolar disorder: focus on BDNF, inflammatory markers, and endothelial function. Curr Psychiatry Rep 2013,15(12),425","journal-title":"Curr Psychiatry Rep"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1177\/0004867413499077","volume":"47","author":"Rege S.","year":"2013","unstructured":"Rege S.; Hodgkinson S.J.; Immune dysregulation and autoimmunity in bipolar disorder: Synthesis of the evidence and its clinical application. Aust N Z J Psychiatry 2013,47(12),1136-1151","journal-title":"Aust N Z J Psychiatry"},{"key":"ref=14","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/360481","author":"Barbosa I.G.","year":"2014","unstructured":"Barbosa I.G.; Bauer M.E.; Machado-Vieira R.; Teixeira A.L.; Cytokines in bipolar disorder: paving the way for neuroprogression. Neural Plast 2014","journal-title":"Neural Plast"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pnpbp.2017.04.028","volume":"77","author":"Tatay-Manteiga A.","year":"2017","unstructured":"Tatay-Manteiga A.; Balanz\u00e1-Mart\u00ednez V.; Bristot G.; Tabar\u00e9s-Seisdedos R.; Kapczinski F.; Cauli O.; Clinical staging and serum cytokines in bipolar patients during euthymia. Prog Neuropsychopharmacol Biol Psychiatry 2017,77,194-201","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.disamonth.2006.05.003","volume":"52","author":"Opara E.C.","year":"2006","unstructured":"Opara E.C.; Oxidative stress. Dis Mon 2006,52(5),183-198","journal-title":"Dis Mon"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jad.2008.04.013","volume":"111","author":"Andreazza A.C.","year":"2008","unstructured":"Andreazza A.C.; Kauer-Sant\u2019anna M.; Frey B.N.; Bond D.J.; Kapczinski F.; Young L.T.; Yatham L.N.; Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord 2008,111(2-3),135-144","journal-title":"J Affect Disord"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/bdi.12418","volume":"18","author":"Mansur R.B.","year":"2016","unstructured":"Mansur R.B.; Santos C.M.; Rizzo L.B.; Cunha G.R.; Asevedo E.; Noto M.N.; Pedrini M.; Zeni M.; Cordeiro Q.; McIntyre R.S.; Brietzke E.; Inter-relation between brain-derived neurotrophic factor and antioxidant enzymes in bipolar disorder. Bipolar Disord 2016,18(5),433-439","journal-title":"Bipolar Disord"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jad.2015.08.058","volume":"188","author":"Rosenblat J.D.","year":"2015","unstructured":"Rosenblat J.D.; Brietzke E.; Mansur R.B.; Maruschak N.A.; Lee Y.; McIntyre R.S.; Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: Evidence, pathophysiology and treatment implications. J Affect Disord 2015,188,149-159","journal-title":"J Affect Disord"},{"key":"ref=20","first-page":"146","volume":"1","author":"Angst J.","year":"2002","unstructured":"Angst J.; Gamma A.; Lewinsohn P.; The evolving epidemiology of bipolar disorder. World Psychiatry 2002,1(3),146-148","journal-title":"World Psychiatry"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.biopsych.2006.02.004","volume":"60","author":"Simon N.M.","year":"2006","unstructured":"Simon N.M.; Smoller J.W.; McNamara K.L.; Maser R.S.; Zalta A.K.; Pollack M.H.; Nierenberg A.A.; Fava M.; Wong K.K.; Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry 2006,60(5),432-435","journal-title":"Biol Psychiatry"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"712","DOI":"10.4088\/JCP.v69n0504","volume":"69","author":"Mur M.","year":"2008","unstructured":"Mur M.; Portella M.J.; Mart\u00ednez-Ar\u00e1n A.; Pifarr\u00e9 J.; Vieta E.; Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients. J Clin Psychiatry 2008,69(5),712-719","journal-title":"J Clin Psychiatry"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1590\/S1516-44462009000400012","volume":"31","author":"Cacilhas A.A.","year":"2009","unstructured":"Cacilhas A.A.; Magalh\u00e3es P.V.; Ceres\u00e9r K.M.; Walz J.C.; Weyne F.; Rosa A.R.; Vieta E.; Kapczinski F.; Bipolar disorder and age-related functional impairment. Br J Psychiatry 2009,31(4),354-357","journal-title":"Br J Psychiatry"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jpsychires.2006.07.013","volume":"41","author":"Andreazza A.C.","year":"2007","unstructured":"Andreazza A.C.; Cassini C.; Rosa A.R.; Leite M.C.; de Almeida L.M.; Nardin P.; Cunha A.B.; Ceres\u00e9r K.M.; Santin A.; Gottfried C.; Salvador M.; Kapczinski F.; Gon\u00e7alves C.A.; Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res [a]2007,41(6),523-529","journal-title":"J Psychiatr Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.psychres.2006.03.025","volume":"153","author":"Andreazza A.C.","year":"2007","unstructured":"Andreazza A.C.; Frey B.N.; Erdtmann B.; Salvador M.; Rombaldi F.; Santin A.; Gon\u00e7alves C.A.; Kapczinski F.; DNA damage in bipolar disorder. Psychiatry Res [b]2007,153(1),27-32","journal-title":"Psychiatry Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.pnpbp.2008.07.001","volume":"32","author":"Kunz M.","year":"2008","unstructured":"Kunz M.; Gama C.S.; Andreazza A.C.; Salvador M.; Ceres\u00e9r K.M.; Gomes F.A.; Belmonte-de-Abreu P.S.; Berk M.; Kapczinski F.; Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008,32(7),1677-1681","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.2174\/092986709788803060","volume":"16","author":"Dean O.M.","year":"2009","unstructured":"Dean O.M.; van den Buuse M.; Bush A.I.; Copolov D.L.; Ng F.; Dodd S.; Berk M.; A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice. Curr Med Chem 2009,16(23),2965-2976","journal-title":"Curr Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/S1734-1140(13)71517-2","volume":"65","author":"Siwek M.","year":"2013","unstructured":"Siwek M.; Sowa-Ku\u0107ma M.; Dudek D.; Stycze\u0144 K.; Szewczyk B.; Kotarska K.; Misztakk P.; Pilc A.; Wolak M.; Nowak G.; Oxidative stress markers in affective disorders. Pharmacol Rep 2013,65(6),1558-1571","journal-title":"Pharmacol Rep"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.pnpbp.2013.03.003","volume":"46","author":"Zhang X.Y.","year":"2013","unstructured":"Zhang X.Y.; Yao J.K.; Oxidative stress and therapeutic implications in psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2013,46,197-199","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1002\/ana.410320706","volume":"32","author":"Floyd R.A.","year":"1992","unstructured":"Floyd R.A.; Carney J.M.; Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann Neurol 1992,32(Suppl.),S22-S27","journal-title":"Ann Neurol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-1-4614-3573-0_6","volume":"748","author":"Dr\u00f6se S.","year":"2012","unstructured":"Dr\u00f6se S.; Brandt U.; Molecular mechanisms of superoxide production by the mitochondrial respiratory chain. Adv Exp Med Biol 2012,748,145-169","journal-title":"Adv Exp Med Biol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrn3229","volume":"13","author":"Manji H.","year":"2012","unstructured":"Manji H.; Kato T.; Di Prospero N.A.; Ness S.; Beal M.F.; Krams M.; Chen G.; Impaired mitochondrial function in psychiatric disorders. Nat Rev Neurosci 2012,13(5),293-307","journal-title":"Nat Rev Neurosci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/archgenpsychiatry.2010.22","volume":"67","author":"Andreazza A.C.","year":"2010","unstructured":"Andreazza A.C.; Shao L.; Wang J.F.; Young L.T.; Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry 2010,67(4),360-368","journal-title":"Arch Gen Psychiatry"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2353\/ajpath.2010.081068","volume":"177","author":"Cataldo A.M.","year":"2010","unstructured":"Cataldo A.M.; McPhie D.L.; Lange N.T.; Punzell S.; Elmiligy S.; Ye N.Z.; Froimowitz M.P.; Hassinger L.C.; Menesale E.B.; Sargent L.W.; Logan D.J.; Carpenter A.E.; Cohen B.M.; Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. Am J Pathol 2010,177(2),575-585","journal-title":"Am J Pathol"},{"key":"ref=35","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.141","volume":"9","author":"Jacoby A.S.","year":"2016","unstructured":"Jacoby A.S.; Vinberg M.; Poulsen H.E.; Kessing L.V.; Munkholm K.; Increased DNA and RNA damage by oxidation in patients with bipolar I disorder. Transl Psychiatry 6-8. e8672016,9","journal-title":"Transl Psychiatry"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.schres.2016.10.037","volume":"187","author":"Kato T.","year":"2017","unstructured":"Kato T.; Neurobiological basis of bipolar disorder: Mitochondrial dysfunction hypothesis and beyond. Schizophr Res 2017,187,62-66","journal-title":"Schizophr Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/ajmg.b.30804","volume":"150B","author":"Kazuno A.A.","year":"2009","unstructured":"Kazuno A.A.; Munakata K.; Mori K.; Nanko S.; Kunugi H.; Nakamura K.; Mori N.; Yamada K.; Yoshikawa T.; Kato N.; Kato T.; Mitochondrial DNA haplogroup analysis in patients with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2009,150B(2),243-247","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neulet.2007.05.016","volume":"421","author":"Machado-Vieira R.","year":"2007","unstructured":"Machado-Vieira R.; Andreazza A.C.; Viale C.I.; Zanatto V.; Cereser V.; da Silva Vargas R.; Kapczinski F.; Portela L.V.; Souza D.O.; Salvador M.; Gentil V.; Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Lett 2007,421(1),33-36","journal-title":"Neurosci Lett"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jpsychires.2010.05.015","volume":"45","author":"Kapczinski F.","year":"2011","unstructured":"Kapczinski F.; Dal-Pizzol F.; Teixeira A.L.; Magalhaes P.V.; Kauer-Sant\u2019Anna, M.; Klamt, F.; Moreira, J.C.; de Bittencourt Pasquali, M.A.; Fries, G.R.; Quevedo, J.; Gama, C.S.; Post, R. Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res 2011,45(2),156-161","journal-title":"J Psychiatr Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.jpsychires.2013.06.018","volume":"47","author":"Gubert C.","year":"2013","unstructured":"Gubert C.; Stertz L.; Pfaffenseller B.; Panizzutti B.S.; Rezin G.T.; Massuda R.; Streck E.L.; Gama C.S.; Kapczinski F.; Kunz M.; Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects. J Psychiatr Res 2013,47(10),1396-1402","journal-title":"J Psychiatr Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jad.2014.10.014","volume":"172","author":"Bengesser S.A.","year":"2015","unstructured":"Bengesser S.A.; Lackner N.; Birner A.; Fellendorf F.T.; Platzer M.; Mitteregger A.; Unterweger R.; Reininghaus B.; Mangge H.; Wallner-Liebmann S.J.; Zelzer S.; Fuchs D.; McIntyre R.S.; Kapfhammer H.P.; Reininghaus E.Z.; Peripheral markers of oxidative stress and antioxidative defense in euthymia of bipolar disorder--Gender and obesity effects. J Affect Disord 2015,172,367-374","journal-title":"J Affect Disord"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/ijnp\/pyx001","volume":"20","author":"Vasconcelos-Moreno M.P.","year":"2017","unstructured":"Vasconcelos-Moreno M.P.; Fries G.R.; Gubert C.; Dos Santos B.T.M.Q.; Fijtman A.; Sartori J.; Ferrari P.; Grun L.K.; Parisi M.M.; Guma F.T.C.R.; Barb\u00e9-Tuana F.M.; Kapczinski F.; Rosa A.R.; Yatham L.N.; Kauer-Sant\u2019Anna, M. Kauer-Sant\u2019Anna, M. Telomere length, oxidative stress, inflammation and BDNF levels in siblings of patients with bipolar disorder: implications for accelerated cellular aging. Int J Neuropsychopharmacol 2017,20(6),445-454","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/0076-6879(90)86141-H","volume":"186","author":"Levine R.L.","year":"1990","unstructured":"Levine R.L.; Garland D.; Oliver C.N.; Amici A.; Climent I.; Lenz A.G.; Ahn B.W.; Shaltiel S.; Stadtman E.R.; Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990,186,464-478","journal-title":"Methods Enzymol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0014-5793(85)81208-4","volume":"22; 187","author":"Wayner D.D.","year":"1985","unstructured":"Wayner D.D.; Burton G.W.; Ingold K.U.; Locke S.; Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. The important contribution made by plasma proteins. FEBS Lett 1985,22; 187(1),33-7","journal-title":"FEBS Lett"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/bj0990667","volume":"99","author":"Wills E.D.","year":"1966","unstructured":"Wills E.D.; Mechanisms of lipid peroxide formation in animal tissues. Biochem J 1966,99(3),667-676","journal-title":"Biochem J"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pneurobio.2004.02.001","volume":"72","author":"Takuma K.","year":"2004","unstructured":"Takuma K.; Baba A.; Matsuda T.; Astrocyte apoptosis: implications for neuroprotection. Prog Neurobiol 2004,72(2),111-127","journal-title":"Prog Neurobiol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"514","DOI":"10.30773\/pi.2016.12.31","volume":"15","author":"Akarsu S.","year":"2018","unstructured":"Akarsu S.; Bolu A.; Aydemir E.; Zincir S.B.; Kurt Y.G.; Zincir S.; Erdem M.; Uzun \u00d6.; The Relationship between the Number of Manic Episodes and Oxidative Stress Indicators in Bipolar Disorder. Psychiatry Investig 2018,15(5),514-519","journal-title":"Psychiatry Investig"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jad.2014.02.018","volume":"159","author":"Bortolasci C.C.","year":"2014","unstructured":"Bortolasci C.C.; Vargas H.O.; Souza-Nogueira A.; Barbosa D.S.; Moreira E.G.; Nunes S.O.; Berk M.; Dodd S.; Maes M.; Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder. J Affect Disord 2014,159,23-30","journal-title":"J Affect Disord"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"194","DOI":"10.5152\/npa.2015.10123","volume":"53","author":"Cingi Yir\u00fcn M.","year":"2016","unstructured":"Cingi Yir\u00fcn M.; \u00dcnal K.; Altunsoy \u015een N.; Yir\u00fcn O.; Aydemir \u00c7.; G\u00f6ka E.; Evaluation of Oxidative Stress in Bipolar Disorder in terms of Total Oxidant Status, Total Antioxidant Status, and Oxidative Stress Index. Noro Psikiyatri Arsivi 2016,53(3),194-198","journal-title":"Noro Psikiyatri Arsivi"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3109\/09637489609012586","volume":"47","author":"Benzie I.F.","year":"1996","unstructured":"Benzie I.F.; Lipid peroxidation: a review of causes, consequences, measurement and dietary influences. Int J Food Sci Nutr 1996,47(3),233-261","journal-title":"Int J Food Sci Nutr"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s11325-011-0589-7","volume":"16","author":"Papandreou C.","year":"2012","unstructured":"Papandreou C.; Schiza S.E.; Tzatzarakis M.N.; Kavalakis M.; Hatzis C.M.; Tsatsakis A.M.; Kafatos A.G.; Siafakas N.M.; Tzanakis N.E.; Effect of Mediterranean diet on lipid peroxidation marker TBARS in obese patients with OSAHS under CPAP treatment: a randomised trial. Sleep Breath 2012,16(3),873-879","journal-title":"Sleep Breath"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neulet.2012.01.060","volume":"14 512","author":"Zortea K.","year":"2012","unstructured":"Zortea K.; Fernandes B.S.; Guimar\u00e3es L.R.; Francesconi L.P.; Lersch C.; Gama C.S.; Schroeder R.; Zanotto-Filho A.; Moreira J.C.; Lobato M.I.; Belmonte-de-Abreu P.S.; Reduced serum non-enzymatic antioxidant defense and increased lipid peroxidation in schizophrenic patients on a hypocaloric diet Neurosci Lett 2012,14 512(1),43-7","journal-title":"Neurosci Lett"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jtemb.2016.09.012","volume":"39","author":"Chowdhury M.I.","year":"2017","unstructured":"Chowdhury M.I.; Hasan M.; Islam M.S.; Sarwar M.S.; Amin M.N.; Uddin S.M.N.; Rahaman M.Z.; Banik S.; Hussain M.S.; Yokota K.; Hasnat A.; Elevated serum MDA and depleted non-enzymatic antioxidants, macro-minerals and trace elements are associated with bipolar disorder. J Trace Elem Med Biol 2017,39,162-168","journal-title":"J Trace Elem Med Biol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/00004850-200403000-00006","volume":"19","author":"Ozcan M.E.","year":"2004","unstructured":"Ozcan M.E.; Gulec M.; Ozerol E.; Polat R.; Akyol O.; Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacol 2004,19(2),89-95","journal-title":"Int Clin Psychopharmacol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.pnpbp.2006.06.011","volume":"31","author":"Frey B.N.","year":"2007","unstructured":"Frey B.N.; Andreazza A.C.; Kunz M.; Gomes F.A.; Quevedo J.; Salvador M.; Gon\u00e7alves C.A.; Kapczinski F.; Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Prog Neuropsychopharmacol Biol Psychiatry 2007,31(1),283-285","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.psychres.2014.04.005","volume":"218","author":"Brown N.C.","year":"2014","unstructured":"Brown N.C.; Andreazza A.C.; Young L.T.; An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Res 2014,218(1-2),61-68","journal-title":"Psychiatry Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jad.2014.10.045","volume":"173","author":"Tsai M.C.","year":"2015","unstructured":"Tsai M.C.; Huang T.L.; Thiobarbituric acid reactive substances (TBARS) is a state biomarker of oxidative stress in bipolar patients in a manic phase. J Affect Disord 2015,173,22-26","journal-title":"J Affect Disord"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/jnc.12316","volume":"127","author":"Andreazza A.C.","year":"2013","unstructured":"Andreazza A.C.; Wang J.F.; Salmasi F.; Shao L.; Young L.T.; Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. J Neurochem 2013,127(4),552-561","journal-title":"J Neurochem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.psychres.2014.11.038","volume":"225","author":"Muti M.","year":"2015","unstructured":"Muti M.; Del Grande C.; Musetti L.; Marazziti D.; Turri M.; Cirronis M.; Pergentini I.; Corsi M.; Dell\u2019Osso L.; Corsini G.U.; Serum uric acid levels and different phases of illness in bipolar I patients treated with lithium. Psychiatry Res 2015,225(3),604-608","journal-title":"Psychiatry Res"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/cbf.940","volume":"20","author":"Kuloglu M.","year":"2002","unstructured":"Kuloglu M.; Ustundag B.; Atmaca M.; Canatan H.; Tezcan A.E.; Cinkilinc N.; Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct 2002,20(2),171-175","journal-title":"Cell Biochem Funct"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/mp.2012.188","volume":"19","author":"Versace A.","year":"2014","unstructured":"Versace A.; Andreazza A.C.; Young L.T.; Fournier J.C.; Almeida J.R.; Stiffler R.S.; Lockovich J.C.; Aslam H.A.; Pollock M.H.; Park H.; Nimgaonkar V.L.; Kupfer D.J.; Phillips M.L.; Elevated serum measures of lipid peroxidation and abnormal prefrontal white matter in euthymic bipolar adults: toward peripheral biomarkers of bipolar disorder. Mol Psychiatry 2014,19(2),200-208","journal-title":"Mol Psychiatry"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/0920-1211(87)90007-6","volume":"1","author":"Krause K.H.","year":"1987","unstructured":"Krause K.H.; Berlit P.; Schmidt-Gayk H.; Schellenberg B.; Antiepileptic drugs reduce serum uric acid. Epilepsy Res 1987,1(5),306-307","journal-title":"Epilepsy Res"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1055\/s-2007-1025263","volume":"205","author":"Fichsel G.","year":"1993","unstructured":"Fichsel G.; Fichsel H.; Liappis N.; [Serum uric acid concentration and anticonvulsant therapy in childhood] Klin Padiatr 1993,205(6),429-431","journal-title":"Klin Padiatr"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/pcn.12631","volume":"72","author":"Dietrich-Muszalska A.","year":"2018","unstructured":"Dietrich-Muszalska A.; Koli\u0144ska-\u0141ukaszuk J.; Comparative effects of aripiprazole and selected antipsychotic drugs on lipid peroxidation in plasma. Psychiatry Clin Neurosci 2018,72(5),329-336","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejphar.2009.10.018","volume":"626","author":"Balanz\u00e1-Mart\u00ednez V.","year":"2010","unstructured":"Balanz\u00e1-Mart\u00ednez V.; Selva G.; Mart\u00ednez-Ar\u00e1n A.; Prickaerts J.; Salazar J.; Gonz\u00e1lez-Pinto A.; Vieta E.; Tabar\u00e9s-Seisdedos R.; Neurocognition in bipolar disorders--a closer look at comorbidities and medications. Eur J Pharmacol 2010,626(1),87-96","journal-title":"Eur J Pharmacol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jad.2013.12.013","volume":"156","author":"Antypa N.","year":"2014","unstructured":"Antypa N.; Serretti A.; Family history of a mood disorder indicates a more severe bipolar disorder. J Affect Disord 2014,156,178-186","journal-title":"J Affect Disord"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1503\/jpn.110061","volume":"37","author":"Fusar-Poli P.","year":"2012","unstructured":"Fusar-Poli P.; Howes O.; Bechdolf A.; Borgwardt S.; Mapping vulnerability to bipolar disorder: a systematic review and meta-analysis of neuroimaging studies. J Psychiatry Neurosci 2012,37(3),170-184","journal-title":"J Psychiatry Neurosci"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1017\/S0033291707001675","volume":"38","author":"Arts B.","year":"2008","unstructured":"Arts B.; Jabben N.; Krabbendam L.; van Os J.; Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med 2008,38(6),771-785","journal-title":"Psychol Med"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1399-5618.2009.00770.x","volume":"12","author":"Ellenbogen M.A.","year":"2010","unstructured":"Ellenbogen M.A.; Santo J.B.; Linnen A.M.; Walker C.D.; Hodgins S.; High cortisol levels in the offspring of parents with bipolar disorder during two weeks of daily sampling. Bipolar Disord 2010,12(1),77-86","journal-title":"Bipolar Disord"},{"key":"ref=70","first-page":"1","author":"Fries G.","year":"2014","unstructured":"Fries G.; Vasconcelos-Moreno M.; Gubert C.; dos Santos B.; Sartori J.; Eisele B.; Ferrari P.; Fijtman A.; R\u00fcegg J.; Gassen N.; Kapczinski F.; Rein T.; Kauer-Sant\u2019Anna, M. Hypothalamic-Pituitary-Adrenal Axis Dysfunction and Illness Progression in Bipolar Disorder. Int J Neuropsychopharmacol 2014,1-10","journal-title":"Int J Neuropsychopharmacol"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/170554","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T18:02:52Z","timestamp":1606672972000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/170554\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,7]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530319666190307165355","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-12-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}